Genetic liability to endometriosis and pregnancy outcomes: a two-sample Mendelian randomization study with maternal-fetal effect decomposition

This two-sample Mendelian randomization study with maternal-fetal effect decomposition provides robust evidence that genetic liability to endometriosis causally increases the risk of placenta praevia through maternal pathways, while suggesting that previously observed associations with other adverse pregnancy outcomes are likely driven by confounding factors rather than direct causality.

The Gist

The Big Question: Is Endometriosis a "Bad Luck" Pregnancy Gene?

Imagine endometriosis as a mischievous gardener who accidentally plants flowers in the wrong part of the garden (the uterus). This causes pain and makes it hard to get pregnant. But once a woman does get pregnant, doctors have long wondered: Does this "mischievous gardener" also cause trouble during the pregnancy itself?

For years, standard medical studies (observational studies) suggested that women with endometriosis had higher risks of:

• The placenta attaching in the wrong spot (Placenta Previa).
• Delivering babies too early (Preterm birth).
• Needing C-sections.
• Bleeding too much after birth.

However, there was a problem: These studies were like watching a movie with the sound off. We saw the characters (endometriosis and bad pregnancy outcomes) acting up together, but we couldn't tell if one caused the other, or if they were just both reacting to a third factor (like the fact that these women often needed fertility treatments, which carry their own risks).

The Detective Tool: Mendelian Randomization (MR)

To solve this mystery, the researchers used a method called Mendelian Randomization. Think of this as a genetic lottery.

1. The Lottery: When you are conceived, you get a random shuffle of genes from your parents. Some people get a "ticket" (genetic variants) that makes them more likely to have endometriosis.
2. The Randomness: Because this lottery happens at conception, it's random. It's not influenced by diet, stress, or how many times a woman went to the doctor.
3. The Experiment: The researchers looked at thousands of women. They asked: "Do the women who won the 'Endometriosis Lottery' (have the genes) actually have more bad pregnancy outcomes?"

If the answer is "Yes," it proves a causal link. It means the biology of endometriosis itself is the culprit, not just the lifestyle or medical treatments surrounding it.

The Investigation: What Did They Find?

The team acted like detectives examining 30 different crime scenes (pregnancy outcomes). They used a massive database of genetic information to see if the "Endometriosis genes" were connected to the "Bad Pregnancy outcomes."

Here is what they discovered:

1. The Smoking Gun: Placenta Previa 🚨

The Finding: There is a strong, real causal link between endometriosis and Placenta Previa.

• What is it? This is when the placenta (the baby's lifeline) attaches too low in the uterus, covering the exit door.
• The Analogy: Imagine the uterus is a house. The placenta is supposed to hang on the front wall. In Placenta Previa, it's stuck on the floor, blocking the front door.
• The Result: Women with the genetic risk for endometriosis were about 60% more likely to have this specific problem. The study found this was a direct biological cause, likely because endometriosis messes up the "soil" (the uterine lining) where the placenta tries to take root.

2. The Red Herrings: The "False Alarms" 🚫

The Finding: For almost everything else, the genetic link disappeared.

• The Suspects: Preterm birth, high blood pressure (preeclampsia), gestational diabetes, bleeding after birth (postpartum hemorrhage), and small babies.
• The Twist: In the old observational studies, these things looked connected to endometriosis. But when the researchers used the "genetic lottery" method, the connection vanished.
• The Explanation: Why did the old studies get it wrong?
  • Confounding: Women with endometriosis often have trouble conceiving. They use fertility drugs (IVF). IVF itself increases the risk of preterm birth and C-sections. The old studies blamed the endometriosis, but it was actually the treatment or the underlying infertility causing the trouble.
  • Over-surveillance: Because doctors know a woman has endometriosis, they watch her pregnancy like a hawk. They might spot a problem earlier or induce labor sooner because they are worried. This makes it look like there are more complications, even if the biology isn't actually causing them.

3. The "Mom vs. Baby" Test: Who is to Blame? 👶👩

The researchers also looked at whether the problem came from the mother's genes or the baby's genes.

• The Result: For almost all outcomes (especially the placenta issues), the problem came from the mother's genetics.
• The Analogy: It's like the mother's "soil" (uterus) is the issue, not the "seed" (the baby). The baby's own genes didn't seem to be the main driver of these complications.

The Takeaway: What Does This Mean for Patients?

This study is a huge relief for many women with endometriosis, but it also gives very specific advice.

1. Stop the Panic: You don't need to worry that endometriosis will automatically cause every type of pregnancy complication. The risk of high blood pressure, diabetes, or bleeding after birth is likely not higher just because you have endometriosis.
2. Focus on the Placenta: The one thing you do need to watch out for is Placenta Previa. Because the "soil" might be tricky, the placenta might attach too low.
3. Targeted Care: Instead of treating every woman with endometriosis as a "high-risk" pregnancy for everything, doctors should focus their extra attention on checking the location of the placenta during ultrasounds.

Summary in One Sentence

Endometriosis is like a gardener who messes up the foundation of the house (causing the placenta to attach in the wrong spot), but it doesn't necessarily mean the whole house is going to collapse (causing other pregnancy disasters); the other risks we thought were linked were mostly just noise from fertility treatments and extra medical monitoring.

Technical Summary

1. Problem Statement

Endometriosis is a chronic estrogen-dependent condition affecting ~10% of reproductive-age women. Observational studies have consistently suggested an association between endometriosis and various adverse pregnancy outcomes, including placental complications (e.g., placenta praevia), preterm birth, caesarean delivery, and hypertensive disorders. However, establishing causality in these observational studies is hindered by:

• Residual Confounding: Socioeconomic status, healthcare utilization, and infertility characteristics.
• Selection Bias: Overrepresentation of women conceiving via Assisted Reproductive Technologies (ART).
• Intermediate Factors: Subfertility and ART use may lie on the causal pathway, confounding the direct effect of the disease.
• Clinical Management: Differential surveillance and intervention rates in women with endometriosis may artificially inflate adverse outcome rates.

The study aims to resolve these ambiguities by using Mendelian Randomization (MR) to estimate the causal effect of genetic liability to endometriosis on a broad spectrum of maternal and perinatal outcomes, while distinguishing between maternal and fetal genetic contributions.

2. Methodology

The authors conducted a two-sample Mendelian randomization study with the following technical specifications:

• Exposure Data:

  • Source: Largest available GWAS meta-analysis for endometriosis (Rahmioglu et al., 2023), comprising 60,674 cases and 701,926 controls (predominantly European ancestry).
  • Instruments: 41 independent genome-wide significant SNPs ($p < 5 \times 10^{-8}$) selected after linkage disequilibrium (LD) clumping ($r^2 < 0.001$).
  • Strength: Mean F-statistic = 279 (indicating strong instruments); $R^2$ = 5.6%.

• Outcome Data:

  • Scope: 30 distinct pregnancy and perinatal outcomes grouped into 9 clinical domains (placental disorders, pregnancy timing, labour/delivery, hypertensive disorders, fetal growth, neonatal outcomes, etc.).
  • Sources: MR-PREG collaboration (up to 714k women), FinnGen Release 12, and a specific PPH GWAS meta-analysis (Westergaard et al.).
  • Ancestry: Predominantly European.

• Statistical Analysis:

  • Primary Method: Inverse-Variance Weighted (IVW) MR.
  • Sensitivity Analyses: MR-Egger, Weighted Median, Weighted Mode, Simple Mode, and MR-PRESSO to detect and correct for horizontal pleiotropy and outliers.
  • Multiple Testing: False Discovery Rate (FDR) correction (Benjamini-Hochberg) applied across all 30 outcomes ($q < 0.05$ considered significant).
  • Triangulation (Maternal-Fetal Decomposition): For 21 outcomes, trio-based models were utilized to disentangle maternal genetic effects (adjusted for fetal genotype) from fetal genetic effects (adjusted for maternal genotype) and paternal effects (negative control).

3. Key Contributions

1. Broad Phenotypic Scope: Unlike previous MR studies limited to a few outcomes, this study systematically evaluated 30 diverse pregnancy outcomes, including specific placental phenotypes often conflated in prior literature.
2. Maternal-Fetal Disentanglement: The study is the first to apply trio-based MR models to endometriosis, explicitly testing whether adverse outcomes are driven by the maternal uterine environment or fetal genetic inheritance.
3. Differentiation of Placental Phenotypes: The study separates placenta praevia (abnormal implantation) from placental abruption/separation (premature detachment), addressing a limitation in previous studies that often grouped them.
4. Robustness Checks: Extensive sensitivity analyses, including leave-one-out (SNP and cohort level) and pleiotropy tests, were performed to ensure result validity.

4. Key Results

A. Primary Findings (FDR-Corrected)

• Placenta Praevia: The only outcome to reach FDR-corrected significance.
  • IVW Estimate: OR 1.62 (95% CI 1.33–1.97; $q < 0.001$).
  • Robustness: Consistent across 4 of 5 sensitivity methods (IVW, Weighted Median, Weighted Mode, Simple Mode). No evidence of pleiotropy or heterogeneity.
• Other Placental Disorders:
  • Premature Placental Separation: Directionally concordant (OR 1.36) but did not survive FDR correction; estimates were imprecise due to lower case numbers.
  • General Placental Disorders: Directionally consistent but imprecise.

B. Null or Non-Robust Findings

• Hypertensive Disorders & Gestational Diabetes: Estimates were consistently near the null (OR $\approx$ 1.0) across all methods, suggesting no causal link.
• Postpartum Haemorrhage (PPH): Null estimates in IVW and most sensitivity methods. MR-Egger suggested a protective effect, but this was likely driven by horizontal pleiotropy (Egger intercept $p < 0.05$) and heterogeneity.
• Preterm Birth: IVW suggested a protective effect (OR 0.83), but this signal disappeared in all sensitivity methods and was entirely driven by a single cohort (ALSPAC) in leave-one-out analyses. This indicates the finding was likely due to cohort-specific ascertainment or pleiotropy, not a causal effect.
• Fetal Growth (SGA/LGA) & Neonatal Outcomes: Most estimates were null. While some exploratory signals for Large for Gestational Age (LGA) were observed in fetal genetic models, they did not survive multiple testing correction.

C. Maternal vs. Fetal Genetic Effects

• Maternal Pathway: For the significant finding (placenta praevia) and most other outcomes, the effect was driven predominantly by maternal genetic pathways.
• Fetal Pathway: Fetal genetic contributions were generally non-significant after correction.
  • Exception: Exploratory signals for fetal genetic effects on birthweight (LGA/High Birthweight) were observed but require independent replication.
• Paternal Pathway: Paternal effects were consistently null, supporting the validity of the maternal genetic instruments and ruling out dynastic effects for most outcomes.

5. Significance and Interpretation

• Mechanistic Insight: The robust causal link specifically with placenta praevia suggests that endometriosis primarily affects early implantation and placentation processes (e.g., impaired decidualization, chronic inflammation in the eutopic endometrium) rather than causing a generalized increase in obstetric risk.
• Clinical Implications:
  • Targeted Surveillance: Women with endometriosis should undergo specific monitoring for abnormal placental location (placenta praevia) during routine ultrasounds.
  • De-escalation of General Risk: The lack of causal evidence for preterm birth, hypertensive disorders, and PPH suggests that previously observed associations in observational studies are likely due to confounding (e.g., ART usage, subfertility) or clinical management patterns (increased surveillance leading to higher detection rates). This argues against a generalized intensification of obstetric surveillance for all endometriosis patients.
• Research Impact: This study sets a new standard for MR in pregnancy research by utilizing trio-based designs to separate maternal intrauterine effects from fetal genetic inheritance, clarifying that the uterine environment is the primary mediator of risk.

Conclusion: Genetic liability to endometriosis causally increases the risk of placenta praevia via maternal pathways related to abnormal implantation. It does not appear to causally increase the risk of preterm birth, hypertensive disorders, or postpartum hemorrhage, indicating that previous observational associations for these outcomes are likely confounded.